Sitagliptin 100 mg Brand Availability
The brand name for sitagliptin 100 mg is Januvia®, and generic sitagliptin 100 mg tablets are also widely available from multiple manufacturers. 1, 2, 3, 4
Available Formulations
Sitagliptin Monotherapy
- Januvia® (brand name): Available as 100 mg tablets for once-daily dosing 4
- Generic sitagliptin: 100 mg tablets available from various manufacturers 5
Fixed-Dose Combinations with Metformin
For patients who may benefit from combination therapy, sitagliptin is also available in fixed-dose combinations:
Janumet® (brand name): Contains sitagliptin/metformin in various strengths including:
Generic fixed-dose combinations: Available as sitagliptin/metformin extended-release tablets in the same strengths 5, 6
Clinical Context for Your Patient
For a 65-year-old man with type 2 diabetes and coronary artery disease who is metformin-intolerant, sitagliptin 100 mg monotherapy is an appropriate choice. 7
Key Considerations:
- Cardiovascular safety: Sitagliptin and linagliptin have demonstrated a neutral effect on heart failure risk and may be considered in patients with cardiovascular disease 7
- Dosing in renal impairment: Maximum dose is 50 mg daily when eGFR is 30-44 mL/min/1.73 m², and 25 mg daily when eGFR is 15-29 mL/min/1.73 m² 8
- Hypoglycemia risk: Low risk when used as monotherapy 4
- Weight effect: Weight neutral 1, 2
Important Caveat:
However, given this patient's established coronary artery disease, guidelines strongly recommend prioritizing SGLT2 inhibitors (empagliflozin, canagliflozin, or dapagliflozin) or GLP-1 receptor agonists (liraglutide, semaglutide, or dulaglutide) over DPP-4 inhibitors like sitagliptin, as these agents have proven cardiovascular mortality and morbidity benefits. 7 Sitagliptin should only be considered if these preferred agents are contraindicated or not tolerated.